Hrast Rambaher M

Title : Dual Cholinergic Modulation in Dementia: Quinuclidine Carbamates Targeting Butyrylcholinesterase and alpha7 Nicotinic Receptor - Mastnak-Sokolov_2025_Chem.Biol.Interact_15ChEPon__111830

Author(s) : Mastnak-Sokolov P , Knez D , Meden A , Strasek Benedik N , Ferjancic Benetik S , Hrast Rambaher M , Zorman M , Nachon F , Brazzolotto X , Jardemark K , Jungholm O , Bruton J , Strandback E , Nyman T , Shahid M , Gobec S

Ref : Chemico-Biological Interactions , :111830 , 2025

Abstract :

PubMedSearch : Mastnak-Sokolov_2025_Chem.Biol.Interact_15ChEPon__111830

PubMedID: 41242410

Gene_locus related to this paper: human-BCHE

Title : Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson's disease - Knez_2024_Bioorg.Chem_153_107877

Author(s) : Knez D , Wang F , Duan WX , Hrast Rambaher M , Gobec S , Cheng XY , Wang XB , Mao CJ , Liu CF , Frlan R

Ref : Bioorg Chem , 153 :107877 , 2024

Abstract :

PubMedSearch : Knez_2024_Bioorg.Chem_153_107877

PubMedID: 39396452

Hrast Rambaher M

References (2)

1. Dual Cholinergic Modulation in Dementia: Quinuclidine Carbamates Targeting Butyrylcholinesterase and alpha7 Nicotinic Receptor - Mastnak-Sokolov_2025_Chem.Biol.Interact_15ChEPon__111830

2. Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson's disease - Knez_2024_Bioorg.Chem_153_107877